VAERS Explorer
Back to explore

Report #2889468

Received Mar 18, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
CA
Recovered
Unknown
Vaccinated
Jan 24, 2025
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TYPTYPHOID LIVE ORAL TY21A (VIVOTIF)BERNA BIOTECH, LTD.1UnknownPO / MO

Symptoms (1)

Incomplete course of vaccination

Symptom narrative

The patient took one dose of Vivotif vaccine and forgot to to take rest of it; Case reference number US-BN-2025-000208 is a spontaneous case initially received from a nurse via Communication (reference number: USBAV25-0305) on 10-Feb-2025 and concerns a 27-years-old, female patient. The patient's medical history and concomitant medication details were not provided. On 24-Jan-2025, the patient took the first dose of Vivotif (batch number: unknown), at dose of one capsule, orally, for indication pre travel. As reported, the patient took one dose of the medication, got really busy and forgot to take the rest of it (explicitly coded as 'incomplete course of vaccination'). At the time of the initial report, it was unknown if the patient experienced any of adverse events due Vivotif. No further information was provided.; Reporter's Comments: A 27-years-old female patient took the first dose of Vivotif, at dose of one capsule, orally, for indication pre travel and forgot to take the rest of it which is considered as incomplete course of vaccination. Incomplete course of vaccination is considered listed per company convention. At the time of the initial report, it was unknown if the patient experienced any of adverse events due Vivotif. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A 27-years-old female patient took the first dose of Vivotif, at dose of one capsule, orally, for indication pre travel and forgot to take the rest of it which is considered as incomplete course of vaccination. Incomplete course of vaccination is considered listed per company convention. At the time of the initial report, it was unknown if the patient experienced any of adverse events due Vivotif. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.

Medical history

Comments: NONE